BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38566349)

  • 21. Local Resection and Brachytherapy for Primary Orbital Rhabdomyosarcoma: Outcome and Failure Pattern Analysis.
    Schoot RA; Saeed P; Freling NJ; Blank LE; Pieters BR; van der Grient JN; Strackee SD; Bras J; Caron HN; Merks JH;
    Ophthalmic Plast Reconstr Surg; 2016; 32(5):354-60. PubMed ID: 26398242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AMORE protocol in pediatric head and neck rhabdomyosarcoma: descriptive analysis of failure patterns.
    Buwalda J; Freling NJ; Blank LE; Balm AJ; Bras J; Voûte PA; Caron HN; Schouwenburg PF; Merks JH
    Head Neck; 2005 May; 27(5):390-6. PubMed ID: 15825203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
    Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
    [No Abstract]   [Full Text] [Related]  

  • 24. Survival after relapse in children and adolescents with rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study Group.
    Pappo AS; Anderson JR; Crist WM; Wharam MD; Breitfeld PP; Hawkins D; Raney RB; Womer RB; Parham DM; Qualman SJ; Grier HE
    J Clin Oncol; 1999 Nov; 17(11):3487-93. PubMed ID: 10550146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapy.
    Viswanathan AN; Grier HE; Litman HJ; Perez-Atayde A; Tarbell NJ; Neuberg D; Shamberger RC; Marcus KJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1208-14. PubMed ID: 15001265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Testicular transposition in children undergoing brachytherapy for bladder and/or prostate rhabdomyosarcoma.
    de Lambert G; Chargari C; Minard-Colin V; Haie-Meder C; Guérin F; Martelli H
    J Pediatr Surg; 2018 Jul; 53(7):1428-1431. PubMed ID: 29753523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second-line chemotherapy.
    Winter S; Fasola S; Brisse H; Mosseri V; Orbach D
    Pediatr Blood Cancer; 2015 Nov; 62(11):1935-41. PubMed ID: 26150380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiotherapy in the Management of Childhood Rhabdomyosarcoma.
    Mandeville HC
    Clin Oncol (R Coll Radiol); 2019 Jul; 31(7):462-470. PubMed ID: 30992168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detailed functional results after bladder-preserving surgery and high-dose-rate brachytherapy in pediatric bladder/prostate rhabdomyosarcoma.
    Ellerkamp V; Schmidt A; Warmann SW; Eckert F; Schaefer J; Paulsen F; Fuchs J
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):3161-3170. PubMed ID: 35879432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V.
    Raney RB; Anderson JR; Barr FG; Donaldson SS; Pappo AS; Qualman SJ; Wiener ES; Maurer HM; Crist WM
    J Pediatr Hematol Oncol; 2001 May; 23(4):215-20. PubMed ID: 11846299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does Routine Imaging of Patients for Progression or Relapse Improve Survival in Rhabdomyosarcoma?
    Lin JL; Guillerman RP; Russell HV; Lupo PJ; Nicholls L; Okcu MF
    Pediatr Blood Cancer; 2016 Feb; 63(2):202-5. PubMed ID: 26376023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complete second look operation and radiotherapy in locally advanced non-alveolar rhabdomyosarcoma in children: A report from the AIEOP soft tissue sarcoma committee.
    Cecchetto G; Carretto E; Bisogno G; Dall'Igna P; Ferrari A; Scarzello G; Donfrancesco A; Alaggio R; Indolfi P; Carli M
    Pediatr Blood Cancer; 2008 Nov; 51(5):593-7. PubMed ID: 18668515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chimeric antigen receptor (CAR) T-cell therapy for people with relapsed or refractory diffuse large B-cell lymphoma.
    Ernst M; Oeser A; Besiroglu B; Caro-Valenzuela J; Abd El Aziz M; Monsef I; Borchmann P; Estcourt LJ; Skoetz N; Goldkuhle M
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013365. PubMed ID: 34515338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of localized liver-bile duct rhabdomyosarcoma according to local therapy: A report from the European Paediatric Soft-Tissue Sarcoma Study Group (EpSSG)-RMS 2005 study.
    Guérin F; Rogers T; Minard-Colin V; Gaze MN; Terwisscha S; Van Noesel M; De Corti F; Guillén Burrieza G; De Salvo GL; Kelsey A; Orbach D; Ferrari A; Bergeron C; Bisogno G; Martelli H
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27725. PubMed ID: 30920113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrospective Analysis of Outcomes of Patients with Relapsed, Refractory and Metastatic Sarcomas who have received Metronomic Chemotherapy.
    Devadas SK; Banavali S
    Gulf J Oncolog; 2019 May; 1(30):22-28. PubMed ID: 31242978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV.
    Pappo AS; Meza JL; Donaldson SS; Wharam MD; Wiener ES; Qualman SJ; Maurer HM; Crist WM
    J Clin Oncol; 2003 Feb; 21(4):638-45. PubMed ID: 12586800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome and Patterns of Relapse in Childhood Parameningeal Rhabdomyosarcoma Treated With Proton Beam Therapy.
    Doyen J; Jazmati D; Geismar D; Frisch S; Schleithoff SS; Vermeren X; Scheer M; Blase C; Tippelt S; Timmermann B
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1043-1054. PubMed ID: 31419513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric extremity rhabdomyosarcoma treated with re-brachytherapy in recurrent setting.
    Kapoor AR; Chandra M; Bhalavat R; Bakshi C; Anchan C; Bauskar P; Markana S
    J Cancer Res Ther; 2022; 18(3):812-816. PubMed ID: 35900564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure pattern and factors predictive of local failure in rhabdomyosarcoma: a report of group III patients on the third Intergroup Rhabdomyosarcoma Study.
    Wharam MD; Meza J; Anderson J; Breneman JC; Donaldson SS; Fitzgerald TJ; Michalski J; Teot LA; Wiener ES; Meyer WH
    J Clin Oncol; 2004 May; 22(10):1902-8. PubMed ID: 15143083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What is new in rhabdomyosarcoma management in children?
    Gosiengfiao Y; Reichek J; Walterhouse D
    Paediatr Drugs; 2012 Dec; 14(6):389-400. PubMed ID: 23050743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.